Abbott Laboratories Stock Swiss Exchange
Stocks
ABT
US0028241000
Medical Equipment, Supplies & Distribution
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 77.50 CHF | +1.97% |
|
+3.33% | -21.72% |
| 07-06 | Evercore ISI Adjusts Abbott Laboratories Price Target to $112 From $120 | MT |
| 07-02 | Missouri jury sides with Enfamil maker Mead Johnson in case over preterm baby formula | RE |
| Market Cap | 164B 144B 133B 123B 233B 15,695B 237B 1,589B 623B 7,707B 617B 604B 26,697B | P/E 2026 * |
23.3x | P/E 2027 * | 19.9x |
|---|---|---|---|---|---|
| Enterprise Value | 176B 154B 142B 131B 250B 16,811B 254B 1,701B 667B 8,255B 661B 647B 28,595B | EV / Sales 2026 * |
3.5x | EV / Sales 2027 * | 3.17x |
| Free-Float |
86.73% | Yield 2026 * |
2.7% | Yield 2027 * | 2.88% |
Last Transcript: Abbott Laboratories
| 1 day | +1.97% | ||
| 1 week | +3.33% | ||
| Current month | +4.03% | ||
| 1 month | +5.44% | ||
| 3 months | -6.06% | ||
| 6 months | -22.50% | ||
| Current year | -21.72% |
| 1 week | 76 |  | 77.5 |
| 1 month | 70.5 | | 77.5 |
| Current year | 65 | | 100 |
| 1 year | 65 | | 106 |
| 3 years | 65 | | 106 |
| 5 years | 65 | | 128 |
| 10 years | 34.75 | | 128 |
| Manager | Title | Age | Since |
|---|---|---|---|
Robert Ford
CEO | Chief Executive Officer | 52 | 2020-03-30 |
Philip Boudreau
DFI | Director of Finance/CFO | 53 | 2023-08-31 |
Sabina Ewing
CIO | Chief Investment Officer | 51 | - |
| Director | Title | Age | Since |
|---|---|---|---|
Sally Blount
BRD | Director/Board Member | 64 | 2011-12-08 |
Nancy McKinstry
BRD | Director/Board Member | 67 | 2011-12-08 |
Daniel Starks
BRD | Director/Board Member | 71 | 2017-02-15 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +1.97% | +3.33% | - | - | 166B | |
| +0.46% | -0.96% | -7.43% | -4.07% | 105B | |
| -2.30% | +2.01% | +0.77% | +58.47% | 60.23B | |
| +0.91% | -3.49% | +40.75% | +56.16% | 49.17B | |
| +0.19% | -4.57% | -14.05% | -41.29% | 41.49B | |
| +1.36% | -5.42% | - | - | 34.08B | |
| -1.40% | +2.48% | -13.96% | -42.37% | 28.58B | |
| +1.13% | -2.21% | +58.13% | -3.75% | 24.99B | |
| -0.67% | -2.02% | -9.64% | +3.00% | 20.64B | |
| +3.11% | -1.01% | -6.61% | -0.85% | 20.42B | |
| Average | +0.48% | -0.82% | +6.00% | +3.16% | 42.73B | |
| Weighted average by Cap. | +0.69% | -0.84% | +4.01% | +8.23% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 50.26B 43.96B 40.54B 37.51B 71.2B 4,797B 72.39B 486B 190B 2,356B 189B 185B 8,160B | 54.75B 47.89B 44.17B 40.86B 77.56B 5,226B 78.86B 529B 207B 2,566B 206B 201B 8,889B |
| Net income | 7.02B 6.14B 5.66B 5.24B 9.94B 670B 10.11B 67.8B 26.58B 329B 26.35B 25.78B 1,139B | 8.39B 7.34B 6.77B 6.26B 11.89B 801B 12.08B 81.05B 31.77B 393B 31.49B 30.81B 1,362B |
| Net Debt | 11.69B 10.23B 9.43B 8.72B 16.56B 1,116B 16.84B 113B 44.27B 548B 43.88B 42.93B 1,898B | 8.86B 7.75B 7.14B 6.61B 12.55B 845B 12.76B 85.57B 33.54B 415B 33.25B 32.53B 1,438B |
| Date | Price | Change |
|---|---|---|
| 26-07-09 | CHF 77.50 | 0.00% |
| 26-07-08 | CHF 77.50 | 0.00% |
| 26-07-07 | CHF 77.50 | +1.97% |
| 26-07-06 | CHF 76.00 | 0.00% |
| 26-07-03 | CHF 76.00 | +1.33% |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- ABT Stock
- ABT Stock
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
